MCO Slips as Shorts Build and the Street Cuts Targets

MCO fell 2.2% on Tuesday to close at $474, giving back most of the post-earnings bounce and widening its underperformance gap against a peer group that added a median 1.8% on the week.

Short interest has climbed steadily since the Q3 print on October 21. Shorts now hold 3.16 million shares, equal to 1.77% of the free float. That is up 8.4% over the past week and 24% over the past month. The absolute level is still low, and borrowing conditions are no constraint. Cost to borrow is 0.41%, barely above the general collateral rate. Availability is extraordinarily loose at 4,569%, meaning roughly 45 shares are available in the lending pool for every one currently borrowed. Short sellers are adding incrementally, but there is no squeeze pressure and no friction in putting on new positions.

The options picture has flipped sharply from the call-heavy setup that preceded the Q3 beat. The put/call ratio has pulled back to 0.60, nearly 1.6 standard deviations below its 20-day average of 0.92. That is still toward the call-friendly end of the past year's range, where the low was 0.44 and the high 1.28. The reading suggests options traders have not abandoned the bullish tilt that took hold before earnings, even as the stock drifted lower this week.

The Street is more cautious than the options market implies. A cluster of analysts updated targets immediately after the Q3 release on October 22. The net message was a modest trim. Morgan Stanley lifted its target by $10 to $480 but kept an Equal-Weight rating, sitting meaningfully below the group. B of A Securities edged its Buy target down $5 to $575. Wells Fargo took $2 off its Overweight target to $595, while Stifel cut from $550 to $537 with a Buy still in place. BMO Capital, holding a neutral Market Perform stance, actually raised its target to $511 from $490, perhaps reflecting the earnings beat. RBC and JP Morgan had both trimmed targets in the days before the print. The mean target across the analyst community is $552, which implies roughly 16% upside from Tuesday's close. That is a wide gap for a company that just reported a quarter the options market liked.

Against its closest peers, MCO's week looks weak. SPGI added 2.5% over the same period. MSCI gained 1.7%, and MORN rose 1.9%. FDS was the exception, down 0.9%. The divergence is notable because these names typically move together, MCO's correlation with SPGI runs at 87%. The underperformance this week is not sector-wide. Something specific to MCO is keeping buyers cautious despite the Q3 beat.

One data point from ORTEX Alt Data adds context. Moody's buyback spend in the April 2026 quarter was $694 million, up 144% on the same quarter a year earlier. That is a significant acceleration in capital return. Remaining buyback authorization hit a record $1.57 billion in Q4 2024, the largest on record since 2018. Neither of these datasets has been measured to lead revenue, so they do not inform the earnings outlook. But the buyback pace does tell you management's own view of value at prices in this range.

The next scheduled earnings event is February 16. Between now and then, the number worth tracking is whether the $552 mean analyst target begins to compress further as more firms digest Q3, or whether the gap to the current price becomes a gravitational pull for buyers.